These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R mBio; 2017 Sep; 8(5):. PubMed ID: 28928215 [TBL] [Abstract][Full Text] [Related]
4. Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth. Qiu Y; Stegalkina S; Zhang J; Boudanova E; Park A; Zhou Y; Prabakaran P; Pougatcheva S; Ustyugova IV; Vogel TU; Mundle ST; Oomen R; Delagrave S; Ross TM; Kleanthous H; Qiu H J Virol; 2020 Feb; 94(6):. PubMed ID: 31826999 [TBL] [Abstract][Full Text] [Related]
5. Universal Influenza Virus Vaccines That Target the Conserved Hemagglutinin Stalk and Conserved Sites in the Head Domain. Krammer F; Palese P J Infect Dis; 2019 Apr; 219(Suppl_1):S62-S67. PubMed ID: 30715353 [TBL] [Abstract][Full Text] [Related]
6. Implications of broadly neutralizing antibodies in the development of a universal influenza vaccine. Cho A; Wrammert J Curr Opin Virol; 2016 Apr; 17():110-115. PubMed ID: 27031684 [TBL] [Abstract][Full Text] [Related]
7. Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets. Krammer F; Hai R; Yondola M; Tan GS; Leyva-Grado VH; Ryder AB; Miller MS; Rose JK; Palese P; García-Sastre A; Albrecht RA J Virol; 2014 Mar; 88(6):3432-42. PubMed ID: 24403585 [TBL] [Abstract][Full Text] [Related]
8. Mutations in the Hemagglutinin Stalk Domain Do Not Permit Escape from a Protective, Stalk-Based Vaccine-Induced Immune Response in the Mouse Model. Roubidoux EK; Carreño JM; McMahon M; Jiang K; van Bakel H; Wilson P; Krammer F mBio; 2021 Feb; 12(1):. PubMed ID: 33593972 [TBL] [Abstract][Full Text] [Related]